30 / 490
28
AWARDS
| PROGRAMME AND EXHIBITION GUIDE
LIFETIME ACHIEVEMENT
MICHAEL BRADA
University of Liverpool & Clatterbridge Cancer Centre
Liverpool, UK
Michael Brada FRCP FRCR DSc is a Professor of Radiation Oncology
at the University of Liverpool and Clatterbridge Cancer Centre;
previously at the Royal Marsden Hospital, London. A leading expert
in neuro-oncology and thoracic oncology and author and co-author
of more than 250 peer-reviewed articles, editorials and book chapters.
As the President of ESTRO (2003-2005) he restored the focus
on education; as the President of EANO (European Association
of Neuro-oncology) nurtured a young organisation towards the
principal European force it is now.
He has been a leader in the development of radiotherapy in neuro-
oncology, with benchmark studies of technical aspects and clinical
outcome of stereotactic radiotherapy and key studies of late toxicity
of cranial irradiation. He made a major contribution to chemotherapy
and radiotherapy in glial tumours and brain metastases. In lung
cancer he developed and tested novel technologies including motion
management techniques and high precision irradiation. Throughout
his career has been a passionate believer in evidence based medicine.
He has a deep interest in improving care and developing and testing
novel methods of follow-up. His studies have resulted in widespread
changes to clinical practice.
His interest in evaluation of novel technologies through systematic
reviews and meta-analyses focusing on benefit to patients have
generated heated debates and continue to irritate “believers” in
technical innovation as a sufficient goal for the future of radiotherapy.
Michael Brada